載入...
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease with no clear etiology and a paucity of therapeutic options. Nintedanib (previously known as BIBF 1120) is a tyrosine kinase receptor antagonist which inhibits a number of key receptors, including those for platelet...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3693725/ https://ncbi.nlm.nih.gov/pubmed/23818761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S38833 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|